Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohnʼs disease: A cautionary tale?
Authors:
- 1 August 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 13 (8) , 1024-1030
Abstract
Therapy for the inflammatory bowel diseases increasingly includes the use of immune-modifying and biologic therapies. Recently, in young patients witKeywords
This publication has 38 references indexed in Scilit:
- Infliximab Use and Hepatosplenic T Cell Lymphoma: Questions to Be Asked and Lessons LearnedJournal of Pediatric Gastroenterology and Nutrition, 2007
- Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I TrialGastroenterology, 2006
- The Hepatitis C Envelope 2 Protein Inhibits LFA-1-Transduced Protein Kinase C Signaling for T-Lymphocyte MigrationGastroenterology, 2006
- Allogeneic Bone Marrow Transplantation for Chemotherapy-Refractory Hepatosplenic γδ T-Cell LymphomaJournal of Pediatric Hematology/Oncology, 2005
- A Cost-Effectiveness Analysis of Alternative Disease Management Strategies in Patients with Crohn's Disease Treated with Azathioprine or 6-MercaptopurineAmerican Journal of Gastroenterology, 2005
- Natalizumab and Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2005
- Risk of haematopoietic cancer in patients with inflammatory bowel diseaseGut, 2005
- Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patientsBlood, 2003
- The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunityBlood, 2002
- Erythrophagocytic Tγ LymphomaNew England Journal of Medicine, 1981